{"id":"W4319939127","doi":"10.1016/j.jtho.2023.01.091","title":"Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC","year":2023,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; National Cancer Institute; National Human Genome Research Institute; NIHR Imperial Biomedical Research Centre; Genentech; G1 Therapeutics; Bayer HealthCare; Jazz Pharmaceuticals; Royal College of Physicians and Surgeons of Canada; Canadian Institutes of Health Research; Associazione Italiana per la Ricerca sul Cancro; GlaxoSmithKline; Northwell Health; Imperial College London; Pfizer; Moderna; Boston Pharmaceuticals; Imperial Experimental Cancer Medicine Centre; Eisai; Wellcome Trust; Relay Therapeutics; Amgen; ViiV Healthcare; Bristol-Myers Squibb; AstraZeneca; National Institute for Health and Care Research; Falk Foundation","keywords":"Chemoimmunotherapy; Medicine; Internal medicine; Oncology; Blockade; Progression-free survival; Chemotherapy; Gastroenterology; Cancer; Immunotherapy; Receptor","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007260622,0.0001585196,0.0003421843,0.000389623,0.0003716863,0.0006878069,0.0002945758,0.0005042561,0.002177075],"category_scores_gemma":[0.002973241,0.0001443241,0.0004093945,0.0005443354,0.0003911401,0.0005242305,0.0002091769,0.0005811603,0.0002839031],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003834617,"about_ca_system_score_gemma":0.0004287758,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007306402,"about_ca_topic_score_gemma":0.001517046,"domain_scores_codex":[0.9996244,0.0001048583,0.00005116694,0.00007222484,0.0000680505,0.00007937341],"domain_scores_gemma":[0.9981276,0.000742561,0.000555106,0.0001477253,0.0001387642,0.0002882916],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009564514,0.0000607186,0.9892582,0.00002431902,0.0001082626,0.0003127185,0.00003417004,0.0002766519,0.00228009,0.00006079085,0.0002255223,0.006402028],"study_design_scores_gemma":[0.00001839698,0.000351649,0.9967238,0.000007765553,0.0001138707,0.0008845591,0.0001218963,0.0004968932,0.0004100734,0.0001400003,0.000725858,0.000005249086],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955372,0.001855893,0.0002060608,0.0002437714,0.00003879493,0.00001310536,0.0002896309,0.00001291399,0.001802713],"genre_scores_gemma":[0.9992605,0.0001501649,0.00006950992,0.00004150721,0.00003634029,0.000005214671,0.0002151536,0.000003463151,0.000218095],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002177075,"threshold_uncertainty_score":0.007283092,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04756961260081242,"score_gpt":0.4393039567090612,"score_spread":0.3917343441082488,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}